532 results on '"Taur, Ying"'
Search Results
2. Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease
3. Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets.
4. Circulating microbial cell–free DNA is increased during neutropenia after hematopoietic stem cell transplantation
5. The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremia
6. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients
7. Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.
8. COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.
9. Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
10. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease
11. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
12. COVID-19 in patients with cancer: can baseline radiologic severity and early evolution predict clinical outcomes?
13. A compilation of fecal microbiome shotgun metagenomics from hematopoietic cell transplantation patients
14. Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
15. Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species
16. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
17. The gut microbiota is associated with immune cell dynamics in humans
18. Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients
19. Author Correction: Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients
20. Projecting COVID-19 disease severity in cancer patients using purposefully-designed machine learning
21. Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis
22. Determinants of COVID-19 disease severity in patients with cancer
23. High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis
24. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients
25. Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer
26. Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
27. A Case of Adult Intestinal Toxemia Botulism During Prolonged Hospitalization in an Allogeneic Hematopoietic Cell Transplant Recipient
28. Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation
29. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT
30. Gut Microbiota and Autism: Key Concepts and Findings
31. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus
32. Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
33. Microbiome in Transplantation
34. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation
35. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection
36. Intestinal Dysbiosis and Markers of Systemic Inflammation in Viscerally and Generally Obese Persons Living With HIV
37. Data from COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
38. SupplementaryTable1.xlsx from COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
39. Supplementary Figure from Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies
40. Supplementary Table from Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies
41. Data from Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies
42. Supplementary Data from Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies
43. Supplementary fig 1 from Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets
44. Supplementary Data1 from Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation
45. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
46. Microbial Bile Acid Metabolism Shapes Effector T Cell Responses during Graft-Versus-Host Disease in Mouse and Human
47. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
48. Role of intestinal microbiota in transplantation outcomes
49. Microbial Bile Acid Metabolism Shapes Effector T Cell Responses during Inflammation in Mouse and Human
50. Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.